AlphaMaven AlphaMaven

Meatly Raises £10.4M Series A To Scale Cultivated Meat Production

Reported by Ventureburn
May 8, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Meatly closes £10.4 million Series A funding round (approximately $14.1–$14.16 million USD) to construct Europe's largest cultivated meat production facility in London.
  • • 20,000-litre bioreactor facility will represent a significant scale-up in European cultivated meat manufacturing capacity, positioning Meatly as a production leader in the sector.
  • • London-based location anchors Meatly's expansion in the UK market, leveraging regulatory clarity and proximity to European distribution networks.
  • • Cultivated meat technology for pet food represents Meatly's initial commercial focus, a lower-cost entry point relative to human food applications and a pathway to near-term revenue generation.
  • • Series A completion signals investor confidence in cultivated meat viability and Meatly's ability to achieve cost reduction milestones necessary for competitive scaling.
Summary
UK-based cultivated meat company Meatly has secured £10.4 million in Series A funding to finance construction of what the company describes as Europe's largest cultivated meat production facility. The facility, to be located in London, will feature a 20,000-litre bioreactor capacity designed to scale commercial production volumes beyond current industry benchmarks in Europe.

The funding round demonstrates sustained institutional confidence in cultivated meat technology despite ongoing industry challenges related to production costs and regulatory approval timelines. Meatly's stated focus on cultivated pet food—rather than human consumption initially—positions the company in a segment with lower regulatory barriers and potentially faster commercialization pathways. This strategic positioning has become increasingly common among cultivated meat developers seeking to establish revenue streams while scaling manufacturing infrastructure.

The Series A capital will be deployed directly toward facility construction and operational scaling. The 20,000-litre bioreactor scale represents a material increase in production capacity relative to current European cultivated meat operations, suggesting Meatly has secured technical validation of its fermentation and cell-culture processes at intermediate scale. Successful deployment of this facility would provide the company with demonstrated manufacturing credentials and cost-reduction data critical for subsequent funding rounds and commercial partnerships.

Meatly's London location reflects broader sectoral trends toward UK-based cultivated meat development, driven by regulatory frameworks that have explicitly authorized cultivated meat research and development activities. The geographic positioning also provides access to European supply chains and potential distribution partnerships across the continent.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Ventureburn Meatly Raises £10.4M Series A To Scale Cultivated Meat Production